Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Case Report

Volume 8, Number 2, June 2019, pages 68-70


Macrophage Activation Syndrome Versus Hemophagocytic Lymphohistiocytosis: A Diagnostic Dilemma in a Patient With Still’s Disease and Epstein-Barr Virus Viremia

Figure

Figure 1.
Figure 1. Overall trend in disease-defining labs. This figure demonstrates white blood cell (WBC) (a), platelet (b), alkaline phosphate (ALP), aspartate transferase (AST), and alanine transferase (ALT) (c) and ferritin (d) levels over the course of admission. Of note, Day 0 represents the day of admission, high dose steroids (dexamethasone 40 mg intravenous) were started on Day 1, and cyclosporine 50 mg twice daily was started on Day 5. The patient was discharged on Day 6, and seen in outpatient follow-up on Day 18.